(3) Exogenously supplemented BMP ligands: BMP9 has been shown to reverse PAH in several models, including BMPRII+/R899X mice, monocrotaline-induced PAH, and Sugen-hypoxia-induced PAH. The gene discussed is GDF2; the disease is pulmonary arterial hypertension.